· By Sanofi Admin

Drug Development 101: Phase 3 Clinical Trials

This post was authored by Terttu Haring, Vice President in Clinical Sciences & Operations, Global Head Trial Operations, Sanofi
If you have been following along with our Drug Development 101 blog series, you will know that we shed light on preclinical research, Phase 1 clinical trials and Phase 2 clinical trials over the course of past […]

VIEW FULL POST
 · By Sanofi Admin

Sanofi Launches Digital Clinical Trials to Improve Recruitment and Reduce Trial Times

Science 37 Logo

Without clinical trials, new medicine may never make it from the research lab to patients in need. These carefully designed studies can provide important data that include proper dosage, benefit to patients, and potential side effects.
There is a growing challenge, however, in finding appropriate participants, especially for treatments that target highly specific conditions affecting narrower […]

VIEW FULL POST